Cavallini Alvise, Marcer Daniela, Ferrari Ruffino Salvatore
Verona medical laser, Verona, Italy.
Phlebology. 2018 Apr;33(3):195-205. doi: 10.1177/0268355516687865. Epub 2017 Jan 29.
Objectives Recurrent varicose veins following surgery is a common, complex and costly problem in vascular surgery. Treatment for RVV is technically more difficult to perform and patient satisfaction is poorer than after primary interventions. Nevertheless, traditional vein surgery has largely been replaced by percutaneous office-based procedures, and the patients with recurrent varicose veins have not benefited from the same advantages. In this paper, we propose an endovascular laser treatment that allows reducing the invasiveness and complications in case of SFJ and SPJ reflux after ligation and stripping of the great and small saphenous vein. Methods 8 SFJ and 1 SPJ stumps were treated by endovascular laser treatment in out-patient clinic. Endovascular laser treatment was performed with a 1470 nm diode laser and a 400 µc radial slim™ fiber. Intraoperative ultrasoud was used to guide the fiber position and the delivery of tumescent anesthesia. The gravity of chronic venous disease was determined according to the CEAP classification and the severity of symptoms was scored according to the revised Venous Clinical Severity Score (VCSS). Results The average linear endovenous energy density was 237 J/cm. Patients return to daily activities after a mean of 1.9 days after. The VCSS improved drastically from a mean of 8 pre-interventional to 1 at day 30 and until one year. During the follow-up period (mean 8 months, range: 5-17 months), all the stumps except one were occluded. All patients were very satisfied or satisfied with the method. No severe complications occurred. Conclusions Office-based endovascular laser treatment of groin and popliteal recurrent varicose veins with 1470 nm diode laser and radial-slim fiber is a safe and highly effective option, with a high success rate in the early post-operative period.
目的 手术后复发性静脉曲张是血管外科中常见、复杂且代价高昂的问题。复发性静脉曲张的治疗在技术上更难实施,且患者满意度低于初次干预后。然而,传统的静脉手术在很大程度上已被基于门诊的经皮手术所取代,而复发性静脉曲张患者并未从同样的优势中获益。在本文中,我们提出一种血管内激光治疗方法,该方法可在大隐静脉和小隐静脉结扎剥脱术后,减少股隐静脉交界处(SFJ)和腘静脉交界处(SPJ)反流情况下的侵袭性和并发症。方法 在门诊对8个SFJ残端和1个SPJ残端进行血管内激光治疗。使用1470 nm二极管激光和400 µc径向纤细™光纤进行血管内激光治疗。术中超声用于引导光纤位置和肿胀麻醉的注射。根据CEAP分类确定慢性静脉疾病的严重程度,并根据修订的静脉临床严重程度评分(VCSS)对症状严重程度进行评分。结果 平均线性静脉内能量密度为237 J/cm。患者平均在1.9天后恢复日常活动。VCSS从干预前的平均8分大幅改善至第30天及直至一年后的1分。在随访期(平均8个月,范围:5 - 17个月)内,除1个残端外,所有残端均闭塞。所有患者对该方法非常满意或满意。未发生严重并发症。结论 使用1470 nm二极管激光和径向纤细光纤对腹股沟和腘窝复发性静脉曲张进行基于门诊的血管内激光治疗是一种安全且高效的选择,术后早期成功率高。